@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/C> a ns1:ATCConcept ;
    dcterms:title "Kardiovaskulární systém"@cs,
        "CARDIOVASCULAR SYSTEM"@en ;
    skos:notation "C" .

<http://linked.opendata.cz/resource/ATC/C09> a ns1:ATCConcept ;
    dcterms:title "Léčiva ovlivňující renin-angiotenzinový systém"@cs,
        "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM"@en ;
    skos:notation "C09" .

<http://linked.opendata.cz/resource/ATC/C09D> a ns1:ATCConcept ;
    dcterms:title "Antagonisté angiotensinu II, kombinace"@cs,
        "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS"@en ;
    skos:notation "C09D" .

<http://linked.opendata.cz/resource/ATC/C09DA> a ns1:ATCConcept ;
    dcterms:title "Antagonisté angiotensinu II a diuretika"@cs,
        "Angiotensin II antagonists and diuretics"@en ;
    skos:notation "C09DA" .

<http://linked.opendata.cz/resource/ATC/C09DA01> a ns1:ATCConcept ;
    dcterms:title "Losartan a diuretika"@cs,
        "Losartan and diuretics"@en ;
    skos:broaderTransitive "http://linked.opendata.cz/resource/ATC/C",
        "http://linked.opendata.cz/resource/ATC/C09",
        "http://linked.opendata.cz/resource/ATC/C09D",
        "http://linked.opendata.cz/resource/ATC/C09DA" ;
    skos:notation "C09DA01" .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0010703> a ns1:Ingredient ;
    ns1:contraindicatedWith "http://linked.opendata.cz/resource/ndfrt/disease/N0000000431",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003529",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ;
    ns1:description "A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.     "@en ;
    ns1:hasPharmacologicalAction "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0006624",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0471877" ;
    ns1:hasPregnancyCategory "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B" ;
    ns1:title "Hydrochlorthiazid"@cs,
        "Hydrochlorothiazide"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0351838> a ns1:Ingredient ;
    ns1:hasPharmacologicalAction "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001326",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0456879" ;
    ns1:title "Losartan potassium"@cs,
        "Losartan potassium"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001326> a ns1:PharmacologicalAction ;
    ns1:description "Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.     "@en ;
    ns1:title "Antiarytmika"@cs,
        "Anti-arrhythmia agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.     "@en ;
    ns1:title "Antihypertenzíva"@cs,
        "Antihypertensive agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0006624> a ns1:PharmacologicalAction ;
    ns1:description "Agents that promote the excretion of urine through their effects on kidney function.     "@en ;
    ns1:title "Diuretika"@cs,
        "Diuretics"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0456879> a ns1:PharmacologicalAction ;
    ns1:description "Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS.     "@en ;
    ns1:title "Blokátory receptoru 1 pro angiotenzin ii"@cs,
        "Angiotensin ii type 1 receptor blockers"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0471877> a ns1:PharmacologicalAction ;
    ns1:description "Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.     "@en ;
    ns1:title "Symportéry pro chlorid sodný - inhibitory"@cs,
        "Sodium chloride symporter inhibitors"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000431> a ns1:DiseaseOrFinding ;
    ns1:title "Anurie"@cs,
        "Anuria"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003529> a ns1:DiseaseOrFinding ;
    ns1:title "Selhání ledvin"@cs,
        "Kidney failure"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> a ns1:DiseaseOrFinding ;
    ns1:title "Těhotenství"@cs,
        "Pregnancy"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162328> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "7"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 7X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162329> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "14"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 14X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162330> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "28"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 28X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162331> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasMaximalPrice "149.559997559"^^xsd:float ;
    ns1:hasPackagingSize "30"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasReimbursementAmount "83.5400009155"^^xsd:float ;
    ns1:hasResumedMarketingDate "2010-10-01"^^xsd:date ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 30X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162332> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "56"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 56X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162333> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "60"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 60X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162334> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasMaximalPrice "447.790008545"^^xsd:float ;
    ns1:hasPackagingSize "90"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasReimbursementAmount "250.619995117"^^xsd:float ;
    ns1:hasResumedMarketingDate "2010-10-01"^^xsd:date ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 90X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162335> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "98"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 98X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162336> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "112"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 112X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162337> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "126"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 126X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162338> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "154"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 154X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162339> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasIndication """Losartan/Hydrochlorothiazid STADA je indikován pro léčbu esenciální hypertenze u pacientů, jejichž krevní tlak není adekvátně kontrolován terapií pomocí samotného losartanu nebo hydrochlorothiazidu.
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "196"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC142257_doc" ;
    ns1:hasStrength "50/12.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL FLM 196X50/12.5MG"@cs ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/LOSARTAN-HYDROCHLOROTHIAZID-STADA-50-MG-12-5-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09DA01" ;
    ns1:hasActiveIngredient "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0010703",
        "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0351838" ;
    ns1:hasMedicinalProductPackaging "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162328",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162329",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162330",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162331",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162332",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162333",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162334",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162335",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162336",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162337",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162338",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0162339" ;
    ns1:hasPregnancyCategory "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B" ;
    ns1:title "LOSARTAN/HYDROCHLOROTHIAZID STADA 50 MG/12,5 MG"@cs .


